Brain Circuitry Therapeutics for Schizophrenia
RecruitingNCT06341517Phase: NAStarted 2024-04-15
Summary
This project is a double blind randomized clinical trials that examines the efficacy of cerebellar non invasive stimulation for apathy improvement in patients with schizophrenia
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
65 Years
Locations
Campus BiotechGeneva, Switzerland
Indrit BègueGeneva, Switzerland
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06341517